|
SFPQ expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.044200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.760000E-02 |
| Normal-vs-Stage2 |
9.630200E-02 |
| Normal-vs-Stage3 |
6.015000E-01 |
| Normal-vs-Stage4 |
2.611200E-01 |
| Stage1-vs-Stage2 |
6.671800E-01 |
| Stage1-vs-Stage3 |
3.170200E-01 |
| Stage1-vs-Stage4 |
9.563200E-01 |
| Stage2-vs-Stage3 |
2.573800E-01 |
| Stage2-vs-Stage4 |
6.636600E-01 |
| Stage3-vs-Stage4 |
4.005000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.318200E-01 |
| Normal-vs-AfricanAmerican |
3.242300E-02 |
| Normal-vs-Asian |
8.578400E-01 |
| Caucasian-vs-AfricanAmerican |
1.142970E-01 |
| Caucasian-vs-Asian |
7.694600E-01 |
| AfricanAmerican-vs-Asian |
3.363400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.313000E-01 |
| Normal-vs-Female |
5.510800E-01 |
| Male-vs-Female |
2.981200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.456100E-02 |
| Normal-vs-Extreme_Weight |
3.069800E-01 |
| Normal-vs-Obese |
2.027000E-01 |
| Normal-vs-Extreme_Obese |
1.152600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.426800E-01 |
| Normal_Weight-vs-Obese |
5.484800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.369600E-01 |
| Extreme_Weight-vs-Obese |
8.303800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.916800E-01 |
| Obese-vs-Extreme_Obese |
4.082000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.321600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.018000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.014600E-01 |
| Normal-vs-Age(81-100Yrs) |
4.465800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.579600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.006200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.546100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.350160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.720500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.008600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.646000E-01 |
| Normal-VS-Type2 PRCC |
1.556150E-04 |
| Normal-VS-KIRP CIMP |
6.838800E-01 |
| Normal-VS-Unclassified PRCC |
2.131800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.58199999999997E-06 |
| Type1 PRCC-VS-KIRP CIMP |
7.398400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.366400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.963800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.662000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.040800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.718400E-02 |
| Normal-vs-N1 |
3.905600E-01 |
| Normal-vs-N2 |
2.437600E-01 |
| N0-vs-N1 |
4.664900E-03 |
| N0-vs-N2 |
7.924800E-01 |
| N1-vs-N2 |
1.686220E-01 |
|
|
